Ground Swell Capital’s Celularity CELU Stock Holding History

Ground Swell Capital’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,483	Closed	-$21.8K	–	175
2024 Q4	$21.8K	Buy	+10,483	New	+$25K	0.03%	120

Other funds holding CELU

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ground Swell Capital's CELU Position: Q1 2025 in Review

Ground Swell Capital sold out of Celularity (CELU) in Q1 2025, closing a stake of 10,483 shares — an estimated $21.8K sold.

Ground Swell Capital first reported a position in CELU in Q4 2024 and held it in 1 quarter. The position peaked at $21.8K in Q4 2024. 29 funds tracked by Wall St. Rank hold CELU as of Q1 2025.

Ground Swell Capital reported no remaining Celularity position as of Q1 2025 after selling out during the quarter.
Ground Swell Capital sold 10,483 Celularity shares in Q1 2025, an estimated $21.8K.
Ground Swell Capital first reported a position in Celularity in Q4 2024 and held it in 1 quarter.
Ground Swell Capital's Celularity position peaked at $21.8K in Q4 2024.
29 funds tracked by Wall St. Rank held Celularity as of Q1 2025.

Based on Ground Swell Capital's 13F filing for Q1 2025, filed 13 May 2025.